Hydrogel interferon formulations
US7879320B2 · kind B2 · utility
1Cited by
20References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 2005 |
| Grant date | Feb 1, 2011 |
| Priority date | — |
| Expiry date | Nov 13, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to pharmaceutical Poloxamer hydrogel formulations containing an interferon. In particular, the invention relates to sustained release hydrogel formulations of interferon-beta, method of preparation and use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.